Head-to-Head

908 Devices Inc. Common Stock vs. 10x Genomics, Inc. Class A Common Stock

MASS

908 Devices Inc. Common Stock

$11.73 +2.62%

VS TXG

10x Genomics, Inc. Class A Common Stock

$69.86 -3.49%

10x Genomics, Inc. Class A Common Stock (TXG) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

MASSTXG
Market Cap $472.44 million $9.10 billion

TXG leads on 1 of 1 size & scale factors.

Risk & Sentiment

MASSTXG
Short Interest 0.62% 0.42%

TXG leads on 1 of 1 risk & sentiment factors.

Dig deeper: MASS overview, MASS financials, TXG overview, TXG financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.